Charles River Labs Intl buy Barclays PLC
Start price
02.10.25
/
50%
€149.30
Target price
02.10.26
€166.12
Performance (%)
15.64%
Price
30.12.25
€172.65
Summary
This prediction is currently active. The prediction currently has a performance of 15.64%. This prediction currently runs until 02.10.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | 0.320% | 0.320% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by Barclays_PLC for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $195.00 price target on the stock, up previously from $165.00.
Ratings data for CRL provided by MarketBeat
Stopped prediction by Barclays_PLC for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€149.35
06.11.25
06.11.25
€182.47
06.11.26
06.11.26
15.60%
30.12.25
30.12.25
